Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same
US11382962B2 · kind B2 · utility
0Cited by
44References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jun 11, 2020 |
| Grant date | Jul 12, 2022 |
| Priority date | — |
| Expiry date | Jun 11, 2040 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Vaccine compositions including a yeast comprising an immunostimulatory polypeptide and optionally an antigenic polypeptide are provided herein. The immunostimulatory polypeptide and the antigenic polypeptide are expressed or displayed on the surface of the yeast vaccine composition. Methods of using the vaccine composition to vaccinate subjects are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.